Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

48.28

+1.35 (2.89%)

Jun 3, 2026, 12:09 PM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Product Revenue, Net	754.05M	677.56M	417.03M
Product Revenue, Net Growth	11.29%	62.47%	78.85%
License and Collaboration Revenue	-	-	6.21M
License and Collaboration Revenue Growth	-	-	-83.25%
Revenue (Total)	754.05M	677.56M	423.24M
Revenue (Total) Growth	11.29%	60.09%	56.61%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States Revenue	753.22M	676.75M	421.43M
United States Revenue Growth	11.30%	60.58%	56.22%
United Kingdom Revenue	823.00K	814.00K	930.00K
United Kingdom Revenue Growth	1.11%	-12.47%	90.96%
Rest of World Revenue	-	-	875.00K
Revenue (Total)	754.05M	677.56M	423.24M
Revenue (Total) Growth	11.29%	60.09%	56.61%

Updated Apr 28, 2026. Data Source: Fiscal.ai.